Treatment of Localized Gingival Recession with Alloderm®, An Acellular Dermal Matrix Allograft: A Six Month Clinical Study.

Aim: Evaluation of root length coverage obtained clinically following use of acellular dermal matrix allograft (alloderm®) in the treatment of class I recession. Methods: The present study included ten individuals who had class I gingival recession on the labial aspect of anterior teeth. Acellular matrix allograft (Alloderm®) was used in this study for gingival recession coverage. Lengh of gingival recession was recorded preoperatively at the time of surgery and post-operatively at 2nd, 4th, 12th and 24th week. Obtained data was statically analyzed. Results: When comparison of mean preoperative and post-operative length of recession (in mm) was done at 180 days all patients showed highly statically significant (p< 0.01) decrease in length of recession from preoperative value. When comparison of mean length of recession was done at 90 and 180 days there was no statically significant (p>0.05) difference in length of recession at 180 days from 90 days. Conclusion: Within the limits of this clinical study the Acellular dermal matrix allograft Alloderm®, is a useful and predictable surgical technique for treatment of gingival recessions. [ABSTRACT FROM AUTHOR]